Comparing the Levels of Gingival Crevicular Fluid Prostaglandin E2 in Generalized Chronic Periodontitis Between Healthy and Type 2 Diabetes Patients: A Case-Control Study

被引:0
作者
Eslami, Hosein [1 ]
Faramarzi, Masoumeh [2 ]
Majidi, Jafar [3 ]
Bohlouli, Sepideh [1 ]
Khani, Anahita Javad [4 ]
Aghebati-Malekio, Leili [3 ]
Motahari, Paria [1 ]
机构
[1] Tabriz Univ Med Sci, Fac Dent, Dept Oral Med, Golgasht Ave, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Dent, Dept Periodontol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Sch Dent, Dept Oral Med, Tabriz, Iran
来源
PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA | 2019年 / 19卷 / 01期
关键词
Periodontal Diseases; Chronic Periodontitis; Diabetes Mellitus; MELLITUS; DISEASE; SECRETION;
D O I
10.4034/PBOCI.2019.191.63
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: To compare the prostaglandin E2 (PGE2) levels of gingival crevicular fluid in generalized chronic periodontitis between healthy and type 2 diabetic patients. Material and Methods: 56 diabetic and non-diabetic participants with generalized chronic periodontitis were selected randomly. They were divided into two groups (G1: generalized chronic periodontitis patients with normal blood sugar; and G2: generalized chronic periodontitis patients with diabetes). Gingival crevicular fluid samples were obtained from both groups. The average of 2 samples per day were centrifuged in a laboratory at 2500 rpm and temperature of 1 degrees C for 5 minutes and placed in a refrigerator at -20 degrees C. The level of PGE2 was measured using ELISA and Abcam kit. Data were analyzed by Kolmogorov-Smirnov, Mann-Whitney U Test, Pearson and independent T tests. The significant amount was considered 0.05 in this test (alpha<0.05). Results: The mean level of PGE2 was significantly different in the two groups and the mean level of PGE2 in the control group was lower than the case group. There was no statistically significant relationship between PGE2 with pocket depth, fasting blood sugar (FBS) and HBA1C (p>0.05). Conclusion: PGE2 level of diabetic patient group with chronic generalized periodontitis was significantly more than non-diabetic group with generalized chronic periodontitis.
引用
收藏
页数:8
相关论文
共 30 条
  • [1] PREVALENCE OF PERIODONTAL-DISEASE IN INSULIN-DEPENDENT DIABETES-MELLITUS (JUVENILE DIABETES)
    CIANCIOLA, LJ
    PARK, BH
    BRUCK, E
    MOSOVICH, L
    GENCO, RJ
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1982, 104 (05) : 653 - 660
  • [2] Oral symptoms and signs in elderly patients with type 2 diabetes mellitus -: A focus on diabetic neuropathy
    Collin, HL
    Niskanen, L
    Uusitupa, M
    Töyry, J
    Collin, P
    Koivisto, AM
    Viinamäki, H
    Meurman, JH
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2000, 90 (03): : 299 - 305
  • [3] Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study
    De Colli, Marianna
    Tortorella, Paolo
    Agamennone, Mariangela
    Campestre, Cristina
    Loiodice, Fulvio
    Cataldi, Amelia
    Zara, Susi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (01) : 651 - 657
  • [4] Oxymatrine alleviates periodontitis in rats by inhibiting inflammatory factor secretion and regulating MMPs/TIMP protein expression
    Deng, Ni
    Xie, Lili
    Li, Yongwei
    Lin, Haishu
    Luo, Renhui
    [J]. ACTA CIRURGICA BRASILEIRA, 2018, 33 (11) : 945 - 953
  • [5] PERIODONTAL-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    EMRICH, LJ
    SHLOSSMAN, M
    GENCO, RJ
    [J]. JOURNAL OF PERIODONTOLOGY, 1991, 62 (02) : 123 - 131
  • [6] Fenske R, 2017, FASEB J, V31
  • [7] PROSTAGLANDIN-E2 LEVELS AND HUMAN PERIODONTAL-DISEASE
    GOODSON, JM
    DEWHIRST, FE
    BRUNETTI, A
    [J]. PROSTAGLANDINS, 1974, 6 (01): : 81 - 85
  • [8] Response to periodontal therapy in diabetics and smokers
    Grossi, SG
    Skrepcinski, FB
    DeCaro, T
    Zambon, JJ
    Cummins, D
    Genco, RJ
    [J]. JOURNAL OF PERIODONTOLOGY, 1996, 67 (10) : 1094 - 1102
  • [9] Higgs G.A., 1974, Prostaglandin synthetase inhibitors, P165
  • [10] Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-B Kinase Activity
    Hirata, Narumi
    Ichimaru, Ryota
    Tominari, Tsukasa
    Matsumoto, Chiho
    Watanabe, Kenta
    Taniguchi, Keita
    Hirata, Michiko
    Ma, Sihui
    Suzuki, Katsuhiko
    Grundler, Florian M. W.
    Miyaura, Chisato
    Inada, Masaki
    [J]. NUTRIENTS, 2019, 11 (02):